Cannabis &amp; Bleeding Disorders

The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation

2024·Review/Other

Probable interaction between warfarin and marijuana smoking

2024·Review/Other

The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies

2024·Review/Other

In vivo effects of Cannabis sativa L. extract on blood coagulation, fat and glucose metabolism in normal and streptozocin-induced diabetic rats

2024·Animal Study -

Marijuana and thromboembolic events in geriatric trauma patients: The cannabinoids clots correlation!

2022·Review/Other

Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in nonhuman primates reduces systemic platelet activity and function

2022·Review/Other

Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders

2021·Review/Other

Δ-9-tetrahydrocannabinol dose increase leads to warfarin drug interaction and elevated INR

2021·Review/Other

Impact of marijuana on venous thromboembolic events: Cannabinoids cause clots in trauma patients

2020·Review/Other

Warfarin dose adjustment required after cannabidiol initiation and titration

2020·Review/Other

Interaction between warfarin and cannabis

2019·Review/Other

An interaction between warfarin and cannabidiol, a case report

2018·Review/Other

Repeated Thrombosis After Synthetic Cannabinoid Use.

2016·Review/Other

2016·Animal Study - Veterinary Clinical Trial

Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity

Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow

2014·Review/Other

Mechanism of platelet activation induced by endocannabinoids in blood and plasma

2014·Review/Other

Ischemic stroke after use of the synthetic marijuana "spice"

2014·Review/Other